Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Liraglutide ameliorated peripheral neuropathy in diabetic rats: Involvement of oxidative stress, inflammation and extracellular matrix remodeling
Passant E. Moustafa, Noha F. Abdelkader, Sally A. El Awdan, et al.
Journal of Neurochemistry (2018) Vol. 146, Iss. 2, pp. 173-185
Open Access | Times Cited: 57

Showing 26-50 of 57 citing articles:

Therapeutic Effects of GLP-1 Receptor Agonists and DPP-4 Inhibitors in Neuropathic Pain: Mechanisms and Clinical Implications
Yaswanth Kuthati, Venkata Naga Goutham Davuluri, Chih‐Shung Wong
Biomolecules (2025) Vol. 15, Iss. 5, pp. 622-622
Open Access
The effects of the GLP1 analog liraglutide on allodynia and motor coordination in peripheral neuropathy induced by a chemotherapeutic agent, cisplatin
Fikriye Yasemin Özatik, Yasemin Tekşen, Orhan Özatik, et al.
Journal of Molecular Histology (2025) Vol. 56, Iss. 3
Closed Access
Preventive role of metformin on peripheral neuropathy induced by diabetes
Deniele Bezerra Lós, Wilma Helena de Oliveira, Eduardo Duarte-Silva, et al.
International Immunopharmacology (2019) Vol. 74, pp. 105672-105672
Closed Access | Times Cited: 28
Oral proniosomal amitriptyline and liraglutide for management of diabetic neuropathy: Exceptional control over hyperglycemia and neuropathic pain
Rana G. Eissa, Noura G. Eissa, Rana A. Eissa, et al.
International Journal of Pharmaceutics (2023) Vol. 647, pp. 123549-123549
Closed Access | Times Cited: 9
Glucagon-like peptide-1 receptor agonists for the management of diabetic peripheral neuropathy
Chunyan Liu, Tianqiang Wu, Na Ren
Frontiers in Endocrinology (2024) Vol. 14
Open Access | Times Cited: 3
The Potential Impact of SGLT2-I in Diabetic Foot Prevention: Promising Pathophysiologic Implications, State of the Art, and Future Perspectives—A Narrative Review
Giuseppe Miceli, Maria Grazia Basso, Andrea Roberta Pennacchio, et al.
Medicina (2024) Vol. 60, Iss. 11, pp. 1796-1796
Open Access | Times Cited: 3
Peripheral Neuropathy Phenotyping in Rat Models of Type 2 Diabetes Mellitus: Evaluating Uptake of the Neurodiab Guidelines and Identifying Future Directions
Md Jakir Hossain, Michael D. Kendig, Meg E. Letton, et al.
Diabetes & Metabolism Journal (2022) Vol. 46, Iss. 2, pp. 198-221
Open Access | Times Cited: 14
In Vitro and Pre-Clinical Evaluation of Locally Isolated Phages, vB_Pae_SMP1 and vB_Pae_SMP5, Formulated as Hydrogels against Carbapenem-Resistant Pseudomonas aeruginosa
Samar S. S. Mabrouk, Ghada R. Abdellatif, Ahmed S. Abu Zaid, et al.
Viruses (2022) Vol. 14, Iss. 12, pp. 2760-2760
Open Access | Times Cited: 13
GLP-1R agonist liraglutide attenuates pain hypersensitivity by stimulating IL-10 release in a nitroglycerin-induced chronic migraine mouse model
Jing Feng, Qian Zou, Yinshuang Pu
Neuroscience Letters (2023) Vol. 812, pp. 137397-137397
Closed Access | Times Cited: 7
Antinociceptive Behavior, Glutamine/Glutamate, and Neopterin in Early-Stage Streptozotocin-Induced Diabetic Neuropathy in Liraglutide-Treated Mice under a Standard or Enriched Environment
Pavlina Andreeva-Gateva, Milen Hristov, Natasha Ivanova, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10786-10786
Open Access | Times Cited: 2
Interleukin-10 Protects Schwann Cells against Advanced Glycation End Products-Induced Apoptosis via NF-κB Suppression
Shiqing Xu, Weijie Bao, Xiuli Men, et al.
Experimental and Clinical Endocrinology & Diabetes (2019) Vol. 128, Iss. 02, pp. 89-96
Open Access | Times Cited: 16
Diagnosing and managing diabetic somatic and autonomic neuropathy
Shazli Azmi, Maryam Ferdousi, Alise Kalteniece, et al.
Therapeutic Advances in Endocrinology and Metabolism (2019) Vol. 10
Open Access | Times Cited: 16
The investigation of therapeutic potential of oxytocin and liraglutide on vincristine‐induced neuropathy in rats
Mümin Alper Erdoğan, Emin Taşkıran, Gürkan Yiğittürk, et al.
Journal of Biochemical and Molecular Toxicology (2019) Vol. 34, Iss. 1
Closed Access | Times Cited: 16
Suppression of BACE1 and amyloidogenic/RAGE axis by sitagliptin ameliorates PTZ kindling-induced cognitive deficits in rats
Marwa M. Safar, Nancy N. Shahin, Ahmed F. Mohamed, et al.
Chemico-Biological Interactions (2020) Vol. 328, pp. 109144-109144
Closed Access | Times Cited: 16
Compound XiongShao Capsule ameliorates streptozotocin-induced diabetic peripheral neuropathy in rats via inhibiting apoptosis, oxidative - nitrosative stress and advanced glycation end products
Meixiang Yu, Bo Lei, Xin Song, et al.
Journal of Ethnopharmacology (2020) Vol. 268, pp. 113560-113560
Closed Access | Times Cited: 14
Effect of exenatide on peripheral nerve excitability in type 2 diabetes
Tushar Issar, Natalie Kwai, Ann M. Poynten, et al.
Clinical Neurophysiology (2021) Vol. 132, Iss. 10, pp. 2532-2539
Closed Access | Times Cited: 12
Activation of pCREB/Nrf-2 signaling mediates re-positioning of liraglutide as hepato-protective for methotrexate -induced liver injury (MILI)
Aya I. Abdelaziz, Eman M. Mantawy, Amany M. Gad, et al.
Food and Chemical Toxicology (2019) Vol. 132, pp. 110719-110719
Closed Access | Times Cited: 13
The effects of taxifolin on neuropathy related with hyperglycemia and neuropathic pain in rats: A biochemical and histopathological evaluation
Murat Alay, Gülçin Miyase Sönmez, Ayşegül Sakin, et al.
Advances in Clinical and Experimental Medicine (2022) Vol. 31, Iss. 4, pp. 427-435
Open Access | Times Cited: 8
The vascular impact of dapagliflozin, liraglutide, and atorvastatin alone or in combinations in type 2 diabetic rat model
Azza Mohammed Hafez El Medany, Sami H. Hammadi, Hoda Khalifa, et al.
Fundamental and Clinical Pharmacology (2022) Vol. 36, Iss. 4, pp. 731-741
Closed Access | Times Cited: 7
Liraglutide modulates olfactory ensheathing cell migration with activation of ERK and alteration of the extracellular matrix
Yu‐Ting Tseng, Mo Chen, Richard Lai, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 141, pp. 111819-111819
Open Access | Times Cited: 7
Ameliorative Impact of Liraglutide on Chronic Intermittent Hypoxia-Induced Atrial Remodeling
Jun Wang, Yongzheng Liu, Changhui Ma, et al.
Journal of Immunology Research (2022) Vol. 2022, pp. 1-13
Open Access | Times Cited: 5
Astaxanthin reduces oxidative stress and alleviates diabetic neuropathy in STZ-induced diabetic mice
Sonal Gaur, Shreshtha Gaur, Rakesh Mishra, et al.
International Journal of Diabetes in Developing Countries (2022) Vol. 43, Iss. 1, pp. 134-144
Closed Access | Times Cited: 4
Anti-inflammatory potential of liraglutide, a glucagon-like peptide-1 receptor agonist, in rats with peripheral acute inflammation
İrem Mert, Ayhan Çetinkaya, Müjgan GÜRLER, et al.
Inflammopharmacology (2022) Vol. 30, Iss. 3, pp. 1093-1105
Open Access | Times Cited: 4
Current and Emerging Pharmacotherapeutic Interventions for the Treatment of Peripheral Nerve Disorders
Jeremy Chung Bo Chiang, Ria Arnold, Roshan Dhanapalaratnam, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 5, pp. 607-607
Open Access | Times Cited: 4
The effect of tropisetron on peripheral diabetic neuropathy: possible protective actions against inflammation and apoptosis
Amir Mohammad Ghazipour, Bagher Pourheydar, Roya Naderi
Cell Stress and Chaperones (2022) Vol. 27, Iss. 5, pp. 513-521
Open Access | Times Cited: 4

Scroll to top